Vaccine Schedule Cost in India: Free vs Paid
Vaccine schedule cost in India explained: which vaccines are free under UIP, NPPA ceiling prices on scheduled vaccines, and private-market cost gaps.
This piece covers exactly what the UIP provides free, how NPPA's ceiling prices work for the vaccines that do carry a cost, and what the private-market cost gap looks like for a hospital advising a paying patient.
Which vaccines are free under India's Universal Immunization Programme?
The UIP, run by the Ministry of Health and Family Welfare's Immunization Division, provides free immunization nationally against diphtheria, pertussis, tetanus, polio, measles, rubella, severe childhood tuberculosis, hepatitis B, and Haemophilus influenzae type B meningitis and pneumonia. Rotavirus diarrhoea, pneumococcal pneumonia and Japanese encephalitis are covered sub-nationally, meaning availability depends on the specific state and district's programme rollout.
The programme serves an estimated 2.67 crore newborns and 2.9 crore pregnant women annually through government hospitals, primary health centres and Anganwadi centres, and has already delivered two major public health outcomes: polio elimination in 2014 and maternal and neonatal tetanus elimination in 2015.
How does NPPA set ceiling prices for scheduled vaccines?
Vaccines listed in India's National List of Essential Medicines fall under NPPA's Drug Price Control Order 2013 ceiling-price mechanism, the same mechanism that caps prices for scheduled medicines generally. NPPA revises these ceiling prices periodically, most recently at its 147th Authority meeting held on 11 June 2026, where it revised prices for anti-tetanus immunoglobulin and several childhood vaccines under Paragraph 19 of the DPCO.
A ceiling price is a maximum, not a fixed retail price: manufacturers can sell below it but not above it, and the figure is revised periodically in line with the Wholesale Price Index. This is the same underlying mechanism NPPA uses for other essential medicines, applied here specifically to vaccines that appear on the price-controlled schedule.
Are all vaccines price-capped the same way?
No. Some newer vaccines have been granted specific exemptions from ceiling-price control rather than being brought under the DPCO schedule immediately on launch, a regulatory tool NPPA uses to encourage domestic manufacturing investment in newer vaccine categories before price control applies. This creates a genuine two-tier vaccine market: older, DPCO-scheduled vaccines carry a government ceiling, while some newer vaccines are priced by the manufacturer within a defined exemption period.
For a hospital advising a paying patient, this distinction matters because "the vaccine is on NPPA's list" does not mean every vaccine in a given category is capped the same way; the specific formulation and its DPCO schedule status need to be checked individually.
What does the private-market cost gap actually look like?
A vaccine's private-market retail price, whether administered at a private hospital, clinic or standalone vaccination centre, is meaningfully higher than what the same vaccine costs the government under its bulk-procurement UIP arrangement. This holds even accounting for GST and administration charges layered on top of the manufacturer's price.
This gap exists across essentially every vaccine category where a government bulk-purchase price and a private retail price both exist. Government procurement volume and negotiated rates are structurally different from single-dose retail pricing, which is the actual driver of the total vaccine schedule cost gap between the two channels.
| Vaccine cost pathway | Who pays | Price basis |
|---|---|---|
| UIP (government schedule) | Free to beneficiary | Government bulk procurement, no patient cost |
| NPPA-scheduled private vaccine | Patient pays | DPCO 2013 ceiling price, revised periodically |
| Exempted/newer private vaccine | Patient pays | Manufacturer-set price during exemption period |
| Combination/travel vaccines outside UIP | Patient pays | Open market, no ceiling |
Mapping a specific vaccine to the right row in this table is the first step in giving a patient an accurate vaccine schedule cost estimate, rather than quoting a single blended number that doesn't reflect which pathway actually applies.
Why does hospital vaccine stocking discipline matter for cost and access?
A hospital or clinic that stocks UIP-eligible vaccines correctly, and refers eligible patients to the free government schedule where appropriate rather than defaulting every patient to a paid private dose, is making a genuine access decision, not just a stocking one.
Where a paid vaccine is medically appropriate, whether an NPPA-capped formulation or an exempted newer one, reliable in-house stock keeps that prescription and the associated vaccine schedule cost inside the hospital rather than sending the patient elsewhere.
Our managed hospital pharmacy services guide covers how an in-house pharmacy keeps vaccine stock reliable and traceable instead of losing that dispensing to an outside chemist or standalone vaccination centre. Our prescription leakage guide covers what that leakage costs a hospital more broadly across its formulary. Our pharmacy inventory management guide covers the cold-chain and expiry discipline vaccine stock specifically demands.
Sources
- 1Universal Immunization Programme (UIP) — National Health Mission, Ministry of Health and Family Welfare
- 2NPPA revises the ceiling prices of eight scheduled drugs to meet the twin objectives of availability and affordability — Press Information Bureau, Government of India
- 3The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 928 scheduled formulations — Press Information Bureau, Government of India
- 4National Pharmaceutical Pricing Authority — Department of Pharmaceuticals, Government of India
- 5National List of Essential Medicines 2022 — Central Drugs Standard Control Organisation
This article is for informational purposes and is not a substitute for professional medical advice. Prices and programme coverage cited here are sourced from official notifications current as of the date checked and change periodically; verify the current figure with NPPA or the Ministry of Health and Family Welfare before relying on it for a billing decision.
FAQ
Frequently asked questions
Vaccines covered under the Universal Immunization Programme are free at government health centres. Some vaccines, and vaccination at private hospitals or clinics generally, carry a cost even when the same vaccine is available free through the government schedule.
No. NPPA sets ceiling prices for vaccines on the DPCO 2013 schedule, revised periodically. Some newer vaccines have been granted exemptions from price control for a defined period, and vaccines outside the essential medicines list are priced by the open market.
The UIP price reflects government bulk procurement at negotiated volume rates and is not charged to the beneficiary at all, while a private-market dose is priced per unit with retail margin, GST and administration charges layered on top.
NPPA revises ceiling prices periodically through its Authority meetings, with revisions typically reflecting Wholesale Price Index movement; the most recent childhood vaccine and immunoglobulin revision was decided at its 147th Authority meeting in June 2026.
Rotavirus vaccine, pneumococcal conjugate vaccine and Japanese encephalitis vaccine are covered sub-nationally under the UIP, meaning free availability depends on the specific state or district's programme rollout rather than being uniform nationwide.
Dr. Priya MenonMBBS, MD (General Medicine)
Consultant Physician (Internal Medicine)
Dr. Priya Menon is a consultant physician in internal medicine, writing on drug classes, side-effect profiles, and evidence-based clinical use for hospital and prescriber audiences.